Sign In
Buy ZEAL
$17.59
+0 (+0%)
At Close: Jan 27, 2023
Zealand Pharma to participate in upcoming investor conferences
04:05pm, Thursday, 25'th Mar 2021
Company announcement – No. 17 / 2020
Company announcement – No. 16 / 2021
Company announcement – No. 15 / 2021
FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings
09:52am, Saturday, 20'th Mar 2021
Biotech stocks reversed course in the week ended March 19 amid mixed news flow on data readouts and lackluster broader market performance. Rubius Therapeutics, Inc. (NASDAQ: RUBY) was among the bigges
Zealand Pharma increases its share capital as a consequence of exercise of employee warrants
11:20am, Friday, 19'th Mar 2021
Company announcement – No. 14 / 2021
Zealand Pharma convenes its Annual General Meeting 2021
12:42pm, Tuesday, 16'th Mar 2021
Company Announcement – No. 13 / 2021
Zealand Pharma A/S (ZEAL) CEO Emmanuel Dulac on Q4 2020 Results - Earnings Call Transcript
04:45pm, Thursday, 11'th Mar 2021
Zealand Pharma A/S (ZEAL) CEO Emmanuel Dulac on Q4 2020 Results - Earnings Call Transcript
Total number of shares and voting rights in Zealand Pharma at February 28, 2021
08:25am, Tuesday, 09'th Mar 2021
Company announcement – No. 11/ 2021
Zealand Pharma Virtual R&D Day Materials Now Available with Live Q&A Session on March 5, 2021
10:00am, Thursday, 04'th Mar 2021
Company announcement – No. 10 / 2021
Zealand Pharma Hosts Conference Call on March 11 at 4 pm CET (10am ET) to Present Full Year Results for 2020
04:00am, Wednesday, 03'rd Mar 2021
Company announcement – No. 9 / 2021
Zealand Pharma to participate in SVB Leerink 9th Annual Global Healthcare Conference
04:05pm, Tuesday, 09'th Feb 2021
Press Release – No. 7 / 2021
Company announcement – No. 6/ 2021
Zealand Pharma completes registration of capital increase
03:47am, Monday, 01'st Feb 2021
Company announcement – No. 4 / 2021
Company announcement – No. 3 / 2021
